Director of Rare Disease Market Access Strategy

Role: Senior leader responsible for developing and executing market access and reimbursement strategies for rare diseases such as SMA and ALS within the US. Objectives include optimizing payer messaging, pricing, contracting, and cross-functional coordination to support brand access across commercial and government segments. Responsibilities involve strategy development, stakeholder engagement, value proposition creation, contracting and pricing innovation, data analysis, and supporting pipeline access activities. The role requires leading cross-functional teams, collaborating with Medical, HEOR, and global teams, and guiding training initiatives. Qualifications: Bachelor's degree (MBA preferred), 10+ years in US market access, payer marketing, or related biotech/pharma fields, with deep knowledge of payer research, financial analyses, and gross-to-net dynamics. Skills include strategic thinking, data translation, presentation ability, and cross-functional collaboration. High-value biopharma specifics: focus on rare disease therapeutics (SMA and ALS), with an emphasis on market access, reimbursement, contracting, and evidence generation. The role reports to the Head of Rare Disease Access Strategy, involves strategic leadership and stakeholder management, and is based in a hybrid or remote setup, with minimal travel expected.